Insiders / Patel Samir Rashmikant
Patel Samir Rashmikant
CIK 1702447unknownbeneficial ownerinsider
Companies
2
First seen
Oct 20, 2021
Last activity
Jul 17, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Akari Therapeutics Plc · AKTX | 5,340,907,500 | — |
| CytoDyn Inc. · CYDY | — | — |
All securities held
7 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Akari Therapeutics Plc | Ordinary shares | 5,340,907,500 |
| Akari Therapeutics Plc | Depositary shares | 101,807 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Akari Therapeutics Plc | Options | 419,511,000 |
| Akari Therapeutics Plc | Warrants | 618,658 |
| Akari Therapeutics Plc | Class B options | 406,250 |
| Akari Therapeutics Plc | Class A options | 406,250 |
| CytoDyn Inc. | Options | 12,329 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | Grant Grant or award | AKTX Akari Therapeutics Plc Ordinary Shares, par value $0.0001 per share | $503.1K | +419.3M +8.71% | 5,235,403,500 5.72% of shares | low |
| Mar 6, 2025 | Grant Grant or award | AKTX Akari Therapeutics Plc American Depositary Shares representing Ordinary Shares | $455.0K | +406K +15.48% | 3,031,005 <0.01% of shares | low |
| Jul 7, 2026 | Exercise Option exercise | AKTX Akari Therapeutics Plc |